Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?-Reference-Cited by-同舟云学术

Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?

Published:2019-02-07 Issue:5 Volume:25 Page:622-631
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Zhang Tong,Huang Zi-Xing,Wei Yi,Jiang Han-Yu,Chen Jie,Liu Xi-Jiao,Cao Li-Kun,Duan Ting,He Xiao-Peng,Xia Chun-Chao,Song Bin

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference24 articles.

1. Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging

2. Advances in managing hepatocellular carcinoma

3. Hepatocellular Carcinoma and Other Hepatic Malignancies

4. Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases

5. 2017 Version of LI-RADS for CT and MR Imaging: An Update

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis;European Radiology;2024-05-29

2. Radiological diagnosis of hepatocellular carcinoma does not preclude biopsy before treatment;JHEP Reports;2024-01

3. Liver Imaging Reporting and Data System (LI-RADS) v2018: differential diagnostic value of ADC values for benign and malignant nodules with moderate probability (LR-3);Frontiers in Oncology;2023-08-22

4. Magnetic Resonance Imaging for Monitoring of Hepatic Disease Induced by Ebola Virus: a Nonhuman Primate Proof-of-Concept Study;Microbiology Spectrum;2023-06-15

5. LI-RADS: Looking Back, Looking Forward;Radiology;2023-04-01